New gene therapy cures 1st New Yorker of sickle cell anemia

Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle cell anemia.
Sickle cell anemia patient reunites with Long Island doctors whose gene therapy treatments made him symptom-free
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after undergoing Lyfgenia, a new type of gene therapy.
Long Island man is first in New York history to be cured of sickle cell anemia
A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. Medical history made at Cohen Children's Medical Center For 21 years,
Man becomes first in New York to be cured of sickle cell
LONG ISLAND, NY (WCBS) - A 21-year-old man has become the first in New York to be cured of sickle cell anemia. “We feel blessed to be the first to be able to offer this,” said Dr. Jonathan Fish with the Cohen Children’s Medical Center.
‘I’m Unstoppable’: New gene therapy cures first New Yorker of sickle cell anemia
Twenty-one-year-old Sebastien Beauzile was all smiles as he was serenaded with “Happy Birthday” on what he calls his new birthday at Cohen Children’s Medical
Gene therapy cures man from sickle cell
A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life. He was Sebastien Beauzile was born with sickle cell anemia and struggled to live a pain free life. However,
Fierce Pharma2d
Amid Vafseo's US launch, Akebia plots phase 3 study to grow CKD anemia med's reach
Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia Therapeutics’ endgame remains focused on pushing the therapy into a wide | ...
Verywell Health on MSN3d
10 Symptoms of Anemia During Pregnancy to Never Ignore
Medically reviewed by Andrea L. Braden, MD If your complete blood count (CBC) lab test shows you are low in healthy red blood ...
Mena FN23d
Anemia Treatment Market Poised For Strong Growth, Expected To Hit USD 19.1 Billion By 2033
Global Anemia Treatment Market size is expected to be worth around USD 19.1 Billion by 2033, from USD 9.7 Billion in 2023, growing at a CAGR of 7.2% Oral Iron Therapy dominates with 35% due to its ...
Business Wire4d
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...
Rolling Out6d
Chronic health issues connected to uterine fibroids
Discover the chronic health complications of uterine fibroids beyond heavy periods, from anemia to fertility concerns, and ...